FLEURY ON NM
Fleury S.A. provides medical services in various areas, including diagnostic, treatment, clinical analysis, health management, and more. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It offers laboratory tests, imaging services, genomics, and other healthcare solutions. Fleury also has a digital healthcare platform called Saúde I for teleconsultations, test results, and electronic medical records.
Overview
Strengths
- With an appreciation Potential of 230.45%, based on our fundamental analysis, it suggests the stock may be undervalued.
- Current Price to Earnings Ratio (11.22) is lower than the sector mean (67.88).
- Price to book ratio (1.31) is lower than the sector mean (9.96).
- The company has high returns. ROIC (20.55%) is higher than the sector mean (7.40%).
- EV/EBITDA (5.14) is lower than the sector mean (36.02).
- EV/EBIT (8.34) is lower than the sector mean.
- Price to free cash flow (4.79) is lower than the sector mean.
- Strong EBITDA Margin of 27.83%.
Weaknesses
- The company has high debt. Net Debt to EBITDA Ratio (1.91) is higher than the sector mean.
Key Financial Data
| Indicator | Value |
|---|
| PER | 11.1 |
| EV/EBITDA | 5.1 |
| Price/Free Cash Flow' | 4.8 |
| ROIC | 20.5% |
| Net Debt/EBITDA | 1.9 |